BLACK DIAMOND THERAPEUTIC's ticker is and the CUSIP is 0920E3105. A total of 1 filers reported holding BLACK DIAMOND THERAPEUTIC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $82,280 | +3.9% | 44,000 | 0.0% | 0.02% | -4.2% |
| Q4 2022 | $79,200 | +5.6% | 44,000 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $75,000 | -99.8% | 44,000 | +41021.5% | 0.02% | -94.8% |
| Q2 2022 | $44,000,000 | +2006.3% | 107 | -99.8% | 0.46% | -2.5% |
| Q1 2022 | $2,089,000 | – | 44,000 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,000 | $75,000 | 0.02% |